机构地区:[1]中国医科大学附属盛京医院麻醉科,沈阳110004
出 处:《中国医师进修杂志》2018年第9期819-822,共4页Chinese Journal of Postgraduates of Medicine
摘 要:目的 观察前锯肌平面阻滞(SAPB)对胸腔镜手术术后镇痛的效果.方法 选择2017年10月至2018年4月择期接受全身麻醉下胸腔镜肺癌根治术的患者60例,采用随机数字表法将患者分为SAPB组(30例)及对照组(30例),全身麻醉诱导后经超声引导施行术侧SAPB,SAPB组注射0.5%的罗哌卡因20 ml,对照组注射等量0.9%氯化钠注射液,术后两组均配制静脉镇疼泵.分别于术后1、2、4、8、12、24和48 h行视觉模拟评分(VAS)和舒适度评分(BCS),同时记录不良反应的发生情况.记录术中瑞芬太尼和术后48 h内额外镇痛药需求量.结果 SAPB组的VAS在术后1、2、4、8和12 h均低于对照组[1 h:(2.70±0.92)分比(5.10±2.04)分、2 h:(2.80±1.00)分比(5.13±1.78)分、4 h:(3.07±1.17)分比(4.93±1.53)分、8 h:(3.13±1.07)分比(4.63±1.47)分、12 h:(2.87±0.73)分比(3.83±1.29)分](P〈0.05);SAPB组的BCS在术后1、2、4、8和12 h优于对照组[1 h:(1.90±0.66)分比(0.93±0.91)分 、2 h:(2.03±0.41)分比(0.90±0.80)分、4 h:(1.90±0.40)分比(1.07±0.69)分、8 h:(1.97±0.32)分比(1.20±0.66)分、12 h:(2.03±0.18)分比(1.73±0.45)分],差异有统计学意义(P〈0.05);且SAPB组术中瑞芬太尼用量及48 h内额外镇痛药需求量均明显少于对照组[(0.23±0.03)mg比(0.34±0.03)mg、(26.67±25.37)mg比(40.00±24.21)mg],差异有统计学意义(P〈0.05);两组不良反应发生率比较差异无统计学意义(P〉0.05).结论 SAPB可减轻胸腔镜肺癌根治术患者术后早期疼痛,提高患者的舒适度,加强术后镇痛的效果并减少术后止疼药的使用量.Objective To investigate the effect of ultrasound-guided serratus plane block (SAPB) on efficacy of postoperative analgesia in patients undergoing video- assisted thoracoscopic surgery. Methods Sixty patients scheduled for video- assisted thoracoscopic radical resection of lung cancer under general anesthesia from October 2017 to April 2018 were divided into 2 groups by random digits table method with 30 cases each: SAPB group and control group. After induction of anesthesia, ultrasound-guided homolateral SAPB was performed, and 0.5% ropivacaine 20 ml was injected in SAPB group, while the equal volume of normal saline was used instead in control group. The patients received intravenous analgesia after operation in 2 groups. The scores of visual analogue score (VAS) and Bruggrmann comfort score (BCS) were evaluated at 1, 2, 4, 6, 12, 24 and 48 h after operation. The consumption of additional pain medication within 48 h after operation and remifentanil during operation were recorded. The adverse effects were also recorded. Results The VAS scores at postoperative 1, 2, 4, 8 and 12 h in SAPB group were significantly lower than those in control group: (2.70 ± 0.92) scores vs. (5.10 ± 2.04) scores, (2.80 ± 1.00) scores vs. (5.13 ± 1.78) scores, (3.07 ± 1.17) scores vs. (4.93 ± 1.53) scores, (3.13 ± 1.07) scores vs. (4.63 ± 1.47) scores and (2.87 ± 0.73) scores vs. (3.83 ± 1.29) scores, P 〈0.05; the BCS scores at postoperative 1, 2, 4, 8 and 12 h in SAPB group were significantly better than those in control group: (1.90 ± 0.66) scores vs. (0.93 ± 0.91) scores, (2.03 ± 0.41) scores vs. (0.90 ± 0.80) scores, (1.90 ± 0.40) scores vs. (1.07 ± 0.69) scores, (1.97 ± 0.32) vs. (1.20 ± 0.66) scores and (2.03 ± 0.18) scores vs. (1.73 ± 0.45) scores, and there were statistical differences (P〈0.05). The dose of remifentanil consumption of additional pain medication within 48 h in SAPB group were significant
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...